Skip to main content


Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 2/2020

Ausgabe 2/2020

Inhaltsverzeichnis ( 26 Artikel )

23.05.2020 | Review | Ausgabe 2/2020

Real-world evaluation of effectiveness and tolerance of chemotherapy for early-stage breast cancer in older women

Glenda M. Delgado-Ramos, Syed Sameer Nasir, Jiajing Wang, Lee S. Schwartzberg

01.06.2020 | Review | Ausgabe 2/2020

Evolution in the risk of adverse events of adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer

Daniel Reinhorn, Rinat Yerushalmi, Assaf Moore, Alexandra Desnoyers, Ramy R. Saleh, Eitan Amir, Hadar Goldvaser

22.05.2020 | Preclinical study | Ausgabe 2/2020 Open Access

Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival

Chitra Joseph, Mansour Alsaleem, Nnamdi Orah, Pavan L. Narasimha, Islam M. Miligy, Sasagu Kurozumi, Ian O. Ellis, Nigel P. Mongan, Andrew R. Green, Emad A. Rakha

23.05.2020 | Clinical trial | Ausgabe 2/2020

Diffusion-weighted MRI at 3.0 T for detection of occult disease in the contralateral breast in women with newly diagnosed breast cancer

Su Min Ha, Jung Min Chang, Su Hyun Lee, Eun Sil Kim, Soo-Yeon Kim, Nariya Cho, Woo Kyung Moon

25.05.2020 | Clinical trial | Ausgabe 2/2020

A comparison of two non-radioactive alternatives to wire for the localization of non-palpable breast cancers

Minna K. Lee, Yas Sanaiha, Amy M. Kusske, Carlie K. Thompson, Deanna J. Attai, Jennifer L. Baker, Cheryce P. Fischer, Maggie L. DiNome

27.05.2020 | Clinical trial | Ausgabe 2/2020 Open Access

Sensory profiles in women with neuropathic pain after breast cancer surgery

L. Mustonen, J. Vollert, A. S. C. Rice, E. Kalso, H. Harno

28.05.2020 | Clinical trial | Ausgabe 2/2020

Intracystic papillary carcinoma: clinical presentation, patterns of practice, and oncological outcomes

Zeina Hassan, Fouad Boulos, Jaber Abbas, Mohamad Hadi El Charif, Hazem Assi, Eman Sbaity

28.05.2020 | Clinical Trial | Ausgabe 2/2020

NSAS-BC02 substudy of chemotherapy-induced amenorrhea (CIA) in premenopausal patients who received either taxane alone or doxorubicin(A) cyclophosphamide(C) followed by taxane as postoperative chemotherapy

Takayuki Iwamoto, Fumikata Hara, Yukari Uemura, Hirofumi Mukai, Toru Watanabe, Yasuo Ohashi

28.05.2020 | Clinical trial | Ausgabe 2/2020

Cumulative incidence of chemotherapy-induced cardiotoxicity during a 2-year follow-up period in breast cancer patients

Hyunsoon Cho, Sanghee Lee, Sung Hoon Sim, In Hae Park, Keun Seok Lee, Mi Hyang Kwak, Hak Jin Kim

28.05.2020 | Clinical trial | Ausgabe 2/2020 Open Access

Predictive risk factors of complications in different breast reconstruction methods

J. S. Palve, T. H. Luukkaala, M. T. Kääriäinen

28.05.2020 | Clinical trial | Ausgabe 2/2020

Cost-effectiveness analysis of endocrine therapy alone versus partial-breast irradiation alone versus combined treatment for low-risk hormone-positive early-stage breast cancer in women aged 70 years or older

Matthew C. Ward, Frank Vicini, Zahraa Al-Hilli, Manjeet Chadha, Lori Pierce, Abram Recht, James Hayman, Nikhil Thaker, Atif J. Khan, Martin Keisch, Chirag Shah

30.05.2020 | Clinical trial | Ausgabe 2/2020

Utilization patterns and temporal trends of internal mammary nodal irradiation at a tertiary cancer center

Shagun Misra, Grace Lee, Manjula Maganti, C. Anne Koch

30.05.2020 | Clinical trial | Ausgabe 2/2020

Risk factors for skeletal-related events in patients with bone metastasis from breast cancer undergoing treatment with zoledronate

Hirotaka Miyashita, Christina Cruz, Stephen Malamud

03.06.2020 | Clinical trial | Ausgabe 2/2020 Open Access

Low-dose metronomic chemotherapy as an efficient treatment option in metastatic breast cancer—results of an exploratory case–control study

S. Krajnak, C. Schnatz, K. Almstedt, W. Brenner, F. Haertner, A.-S. Heimes, A. Lebrecht, G.-M. Makris, R. Schwab, A. Hasenburg, M. Schmidt, M. J. Battista

04.06.2020 | Clinical trial | Ausgabe 2/2020 Open Access

Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study

Giuseppe Buono, Anna Crispo, Mario Giuliano, Carmine De Angelis, Francesco Schettini, Valeria Forestieri, Rossella Lauria, Michelino De Laurentiis, Pietro De Placido, Carmen Giusy Rea, Carmen Pacilio, Emanuela Esposito, Maria Grimaldi, Flavia Nocerino, Giuseppe Porciello, Aldo Giudice, Alfonso Amore, Anita Minopoli, Gerardo Botti, Sabino De Placido, Meghana V. Trivedi, Grazia Arpino

21.05.2020 | Epidemiology | Ausgabe 2/2020

Radiation and/or endocrine therapy? Recurrence and survival outcomes in women over 70 with early breast cancer after breast-conserving surgery

Hannah Dahn, Derek Wilke, Gordon Walsh, Jean-Philippe Pignol

22.05.2020 | Epidemiology | Ausgabe 2/2020

Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers

Deborah Cragun, Anne Weidner, Ann Tezak, Kate Clouse, Tuya Pal

25.05.2020 | Epidemiology | Ausgabe 2/2020

Does oncoplastic surgery increase immediate (30-day) postoperative complications? An analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database

Fernando A. Angarita, Sergio A. Acuna, Erin Cordeiro, David R. McCready, Tulin D. Cil

28.05.2020 | Epidemiology | Ausgabe 2/2020

Overall health at diagnosis predicts the risk of complications within the first year after breast cancer diagnosis

Cecilia T. Ong, Yi Ren, Samantha M. Thomas, Ilona Stashko, Terry Hyslop, Gretchen Kimmick, Rachel C. Blitzblau, E. Shelley Hwang, Lars J. Grimm, Rachel A. Greenup

28.05.2020 | Epidemiology | Ausgabe 2/2020 Open Access

Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study

Anna H. Wu, Chiuchen Tseng, Cheryl Vigen, Yang Yu, Wendy Cozen, Agustin A. Garcia, Darcy Spicer

02.06.2020 | Epidemiology | Ausgabe 2/2020

Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis

Blanche P. Alter, Ana F. Best

03.06.2020 | Epidemiology | Ausgabe 2/2020 Open Access

Stage-specific survival has improved for young breast cancer patients since 2000: but not equally

Cassia Bree Trewin, Anna Louise Viktoria Johansson, Kirsti Vik Hjerkind, Bjørn Heine Strand, Cecilie Essholt Kiserud, Giske Ursin

03.06.2020 | Epidemiology | Ausgabe 2/2020

Simple prediction model for homologous recombination deficiency in breast cancers in adolescents and young adults

Tomoko Watanabe, Takayuki Honda, Hirohiko Totsuka, Masayuki Yoshida, Maki Tanioka, Kouya Shiraishi, Yoko Shimada, Eri Arai, Mineko Ushiama, Kenji Tamura, Teruhiko Yoshida, Yae Kanai, Takashi Kohno

21.05.2020 | Brief report | Ausgabe 2/2020

Somatic mutations of triple-negative breast cancer: a comparison between Black and White women

Angela R. Omilian, Lei Wei, Chi-Chen Hong, Elisa V. Bandera, Song Liu, Thaer Khoury, Christine B. Ambrosone, Song Yao

26.05.2020 | COVID-19 | Letter to the Editor | Ausgabe 2/2020 Zur Zeit gratis

Response to the article by Dietz et al. entitled “Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID‑19 pandemic. The COVID‑19 pandemic breast cancer consortium”

Peter Beitsch, Pat Whitworth, Rakesh Patel

21.05.2020 | Rebuttal Letter | Ausgabe 2/2020

Reply to letters to the editor: Discordance in estrogen receptor and change of Ki67 between primary site and metastatic site of recurrent breast cancer

Junichiro Watanabe

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.